Respiratory tularemia: comparison of selected routes of vaccination in Fischer 344 rats
- PMID: 7333669
- PMCID: PMC350937
- DOI: 10.1128/iai.34.3.766-772.1981
Respiratory tularemia: comparison of selected routes of vaccination in Fischer 344 rats
Abstract
Fischer 344 rats were given the attenuated live vaccine strain of Francisella tularensis by small-particle aerosol, intranasal instillation, or intraperitoneal, intramuscular, or subcutaneous injection. All of the vaccinated rats developed subclinical infection by 3 days after exposure, which cleared by day 28. Temporal patterns and concentrations of the live vaccine strain organism within the hosts were dependent on the route of vaccination. Pathological alterations were limited to minimal lung lesions in aerosol-vaccinated rats and mild splenitis in intraperitoneally vaccinated rats. Agglutinins to live vaccine strain were detected in the serum of each vaccinated animal and in the bronchoalveolar wash fluids of 66% of the aerosol-vaccinated rats. Agglutinin activity of the vaccinated rats was associated predominantly with the immunoglobulin M class. Regardless of the route of vaccine administration, all vaccinated rats survived an aerosol challenge of 5.3 log10 cells of virulent F. tularensis, whereas all nonvaccinated rats died. Systemic infection did not occur in the vaccinated rats. Pulmonary infection was not prevented in the vaccinated rats after aerosol challenge, but proliferation of the virulent F. tularensis organisms in the lungs was significantly lower (analysis of variance, P less or equal to 0.01) than that which occurred in the control animals. These studies demonstrate the utility of the inbred Fischer 344 rat as a model host for further investigations of F. tularensis infection and its associated immune response.
Similar articles
-
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.Pathog Dis. 2016 Oct;74(7):ftw079. doi: 10.1093/femspd/ftw079. Epub 2016 Aug 9. Pathog Dis. 2016. PMID: 27511964 Free PMC article.
-
Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Infect Immun. 2007 May;75(5):2152-62. doi: 10.1128/IAI.01606-06. Epub 2007 Feb 12. Infect Immun. 2007. PMID: 17296747 Free PMC article.
-
Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains.Vaccine. 2009 Jul 23;27(34):4684-93. doi: 10.1016/j.vaccine.2009.05.060. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520198 Free PMC article.
-
[Aerosol vaccination against dangerous infectious diseases].Vestn Ross Akad Med Nauk. 1999;(8):47-54. Vestn Ross Akad Med Nauk. 1999. PMID: 10487124 Review. Russian.
-
Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.Microbes Infect. 2003 Feb;5(2):135-42. doi: 10.1016/s1286-4579(02)00084-9. Microbes Infect. 2003. PMID: 12650771 Review.
Cited by
-
In vivo and in vitro immune responses against Francisella tularensis vaccines are comparable among Fischer 344 rat substrains.Front Microbiol. 2023 Jul 13;14:1224480. doi: 10.3389/fmicb.2023.1224480. eCollection 2023. Front Microbiol. 2023. PMID: 37547680 Free PMC article.
-
Development, Phenotypic Characterization and Genomic Analysis of a Francisella tularensis Panel for Tularemia Vaccine Testing.Front Microbiol. 2021 Aug 11;12:725776. doi: 10.3389/fmicb.2021.725776. eCollection 2021. Front Microbiol. 2021. PMID: 34456897 Free PMC article.
-
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.PLoS One. 2024 May 7;19(5):e0294998. doi: 10.1371/journal.pone.0294998. eCollection 2024. PLoS One. 2024. PMID: 38713688 Free PMC article.
-
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.Pathog Dis. 2016 Oct;74(7):ftw079. doi: 10.1093/femspd/ftw079. Epub 2016 Aug 9. Pathog Dis. 2016. PMID: 27511964 Free PMC article.
-
An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia.J Immunol Res. 2018 Nov 29;2018:8087916. doi: 10.1155/2018/8087916. eCollection 2018. J Immunol Res. 2018. PMID: 30622981 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical